The recent decision of the Federal Court of Australia in the a2 Milk Company Limited v Care A2 Plus Pty Ltd is one of the more significant Australian trade mark judgments delivered in the food and dairy sector in recent years. The dispute sat at the intersection of branding, consumer perception, scientific terminology, and trade mark distinctiveness. It also raised an important commercial question that extends well beyond the dairy industry, i.e. when does a scientific or descriptive expression become so strongly connected with one trader that it functions as a badge of origin?
Justice Rofe was required to deal with a wide range of issues across both infringement and invalidity proceedings. It concerned the well-known “a2 Milk” branding used by The a2 Milk Company Limited (a2MC), and the conduct of Care A2 Plus Pty Ltd and associated entities, which marketed infant formula and related products using “Care A2+” branding.
The main issue was the argument that “a2” was descriptive of a type of milk protein and therefore incapable of functioning as a distinctive trade mark. On the other side was a2MC’s position that years of extensive commercial use, advertising, consumer recognition, and brand development had transformed “a2” into a powerful indicator of trade origin.
The Court ultimately ruled in favour of a2MC on the major issues. The decision provides detailed guidance on deceptive similarity, composite branding, acquired distinctiveness, descriptive use, and consumer confusion under both the Trade Marks Act 1995 (Cth) and the Australian Consumer Law.
Background of the Dispute
The a2 Milk Company Limited is widely known for marketing milk products associated with the “A2 beta-casein” protein. Over time, the company developed a substantial portfolio of Australian trade marks incorporating the terms “a2” and “a2 Milk”. Those registrations covered products including milk, dairy goods, and infant formula.
Care A2 Plus Pty Ltd operated in the infant and toddler formula market. Alongside related corporate entities, it manufactured and promoted formula products using branding that prominently featured the expressions “Care A2+” and “A2+”. The branding appeared across product packaging, websites, investor materials, sponsorship activities, and retail channels.
The dispute eventually led to two connected proceedings before the Federal Court.
In the infringement proceedings, a2MC alleged that the Care A2 Parties infringed five registered trade marks and engaged in misleading or deceptive conduct under the Australian Consumer Law. The company argued that the use of “A2+” and “Care A2+” branding created an impression of association with the established a2 Milk business.
In separate invalidity proceedings, Care A2 sought cancellation of the a2MC trade marks. The challenge relied on several statutory grounds, including lack of distinctiveness, descriptiveness, absence of intention to use, and allegations that the marks were likely to mislead consumers.
The Scientific Context Behind “A2” Milk
An unusual feature of the dispute was the scientific background surrounding the term “A2”. Unlike invented expressions such as “Kodak” or “Xerox”, the term “A2” has scientific meaning within the dairy industry.
Cow’s milk contains beta-casein proteins. Certain cows produce milk containing the A1 protein variant, while others produce milk containing the A2 variant. a2MC built an entire commercial identity around products associated with the A2 beta-casein profile.
Care A2 argued that because “A2” described a naturally occurring protein type, the expression should remain available for all traders in the dairy industry to use. According to Care A2, no single business should obtain a monopoly over terminology with genuine scientific significance.
That argument carried obvious force. Trade mark law generally resists granting exclusive rights over descriptive or technical language that competitors may honestly need to use in the course of trade.
However, the Court approached the issue with greater nuance.
Justice Rofe acknowledged that “A2” possesses scientific meaning. Yet the Court also recognized that trade marks are evaluated within their real commercial context. The key issue was not whether “A2” had descriptive elements in isolation. The real question was whether Australian consumers had come to understand the marks as identifying the commercial origin of goods.
That distinction became central throughout the judgment.
The Extensive Reputation Built by a2MC
A substantial portion of the evidence focused on the commercial reputation developed by a2MC over many years.
The company produced evidence relating to extensive advertising campaigns; product packaging; supermarket sales; media exposure; brand recognition studies; sponsorship activities; historical consumer awareness surveys; turnover and sales growth; and enforcement activity against third parties.
The Court noted significant increases in sales and market recognition over time. Evidence showed that a2MC had consistently promoted “a2” and “a2 Milk” as distinctive brands rather than merely scientific descriptions.
The Court also considered expert evidence from lexicology and marketing specialists. That evidence addressed how ordinary consumers perceive the expressions “a2” and “a2 Milk” in the marketplace.
Justice Rofe accepted that consumers did not merely view “a2” as a technical protein classification. Rather, many consumers associated the term directly with a2MC and its products.
This finding substantially weakened Care A2’s descriptiveness arguments.
The Infringement Claims
The infringement analysis focused heavily on whether the impugned signs were used “as trade marks” and whether they were deceptively similar to the registered a2MC marks.
The Court examined various forms of conduct by the Care A2 Parties, including the infant formula packaging; the “Care A2 Plus” website; investor communications; retail and promotional materials; and sponsorship branding associated with the Kooyong Classic tennis event.
One important legal question was whether “Care A2+” functioned as one composite mark or whether the “A2+” element separately operated as a badge of origin.
That distinction mattered because packaging and branding can contain multiple trade marks simultaneously. A house brand may appear alongside product-specific indicators.
Justice Rofe held that consumers would perceive “A2+” as functioning independently and prominently within the branding. The Court did not accept that the addition of the word “Care” eliminated the significance of the “A2+” element.
The judgment repeatedly emphasized the visual and conceptual prominence of “A2+” across the impugned conduct.
Deceptive Similarity
The Court then turned to the question of deceptive similarity.
Under Australian trade mark law, marks are deceptively similar where they so nearly resemble each other that they are likely to deceive or cause confusion.
The analysis is not performed through side-by-side comparison in perfect conditions. Instead, courts assess the imperfect recollection of ordinary consumers operating in real commercial environments.
Justice Rofe concluded that the “A2+” mark was deceptively similar to the a2MC marks.
Several factors influenced this conclusion.
Firstly, the dominant feature of both signs was the expression “A2”. Secondly, the addition of the “+” symbol did little to distinguish the marks conceptually or visually. Thirdly, the goods involved were closely related, particularly within the infant formula and dairy categories.
The Court also considered the strength of a2MC’s existing reputation. Because the a2MC marks had become widely recognized, there was a greater risk that consumers encountering “A2+” branding would assume some form of association, licensing arrangement, product extension, or commercial connection.
The Court therefore held that the use of “A2+” infringed the registered marks.
However, Justice Rofe reached a more nuanced conclusion regarding the broader “Care A2+” composite mark. The Court considered that the full composite expression was not itself deceptively similar to the registered marks when assessed as a whole.
This distinction is important.
The judgment demonstrates that one element within composite branding may infringe even where the broader composite mark avoids deceptive similarity in its entirety.
The Invalidity Challenge
Care A2’s invalidity case was ambitious. The company sought cancellation or rectification of the a2MC registrations on multiple grounds under the Trade Marks Act.
The key arguments focused on lack of inherent distinctiveness under section 41; misleading or deceptive characteristics under section 42; absence of intention to use under section 59; descriptiveness under section 24; and arguments linked to expired patents under section 25.
Most of these arguments ultimately failed.
Distinctiveness Under Section 41
The distinctiveness arguments formed the main point of the invalidity challenge.
Care A2 argued that “a2” and “a2 Milk” were ordinary descriptive expressions referring to milk containing the A2 beta-casein protein. According to Care A2, other dairy traders needed to use the terminology honestly in connection with their products.
Justice Rofe accepted that the terms possessed descriptive characteristics to some degree. Yet the Court found that the marks had acquired factual distinctiveness through extensive commercial use.
This part of the judgment is especially important for businesses using marks that sit close to descriptive language.
Australian trade mark law does not treat distinctiveness as a rigid or binary concept. A mark may initially possess limited inherent distinctiveness but later acquire strong trade mark significance through sustained market use.
The Court concluded that by the relevant filing dates, the marks had become strongly associated with a2MC in the minds of consumers.
Evidence relating to advertising expenditure, sales figures, consumer surveys, and brand awareness played a substantial role in this outcome.
The judgment therefore reinforces the evidentiary value of long-term brand development.
The Court’s Treatment of Consumer Perception
One of the more interesting aspects of the decision is the Court’s detailed attention to consumer behavior.
Justice Rofe repeatedly approached the dispute from the perspective of ordinary purchasers rather than industry specialists.
That distinction mattered because scientifically informed traders may understand “A2” as a technical protein classification. Consumers, however, may perceive the same expression very differently.
The Court recognized that trade mark law ultimately protects commercial source identification, not scientific purity.
Even where language possesses technical meaning, extensive branding can reshape public perception over time.
This reasoning aligns with broader principles in Australian trade mark jurisprudence. Courts frequently distinguish between how experts interpret terminology and how ordinary consumers actually encounter branding in supermarkets, pharmacies, online stores, or advertising.
The judgment therefore serves as a reminder that evidence of real-world consumer recognition can outweigh abstract linguistic arguments.
Misleading or Deceptive Conduct
The Court also considered claims under the Australian Consumer Law.
a2MC argued that the conduct of the Care A2 Parties conveyed misleading impressions regarding association, endorsement, or commercial connection.
Justice Rofe examined the overall context in which consumers encountered the impugned branding. This included packaging design, product presentation, marketing channels, sponsorship activities, and the reputation already attached to the a2MC marks.
The Court concluded that a not insignificant number of consumers were likely to be misled or confused. Actual confusion evidence was also considered.
Australian courts do not require proof that large numbers of consumers were in fact deceived. The likelihood or real risk of confusion is sufficient. Nevertheless, evidence of actual confusion can strengthen an infringement or misleading conduct case considerably.
The Court found that the surrounding circumstances reinforced the likelihood that consumers would draw a connection between the Care A2 branding and the established a2MC business.
“No Intention to Use” Allegation
Care A2 also alleged that a2MC lacked a genuine intention to use certain trade marks at the time of filing. This argument failed.
Justice Rofe found that the evidence demonstrated genuine commercial intention and extensive actual use over time.
The Court’s reasoning reflects the relatively high threshold required to invalidate marks under section 59. Mere criticism of branding strategy or enforcement conduct is generally insufficient. Strong evidence is required to establish that an applicant never intended to use the mark genuinely in trade.
No such evidence existed here.
Patent-Related Arguments
An especially technical aspect of the case involved section 25 of the Trade Marks Act, which concerns trade marks connected to formerly patented products.
Care A2 attempted to argue that the relevant marks should not remain protected because they related to products previously associated with expired patents.
The Court carefully reviewed the specifications and technical content of the patents relied upon.
That said, Justice Rofe did not accept that the statutory requirements for cancellation under section 25 had been established.
Although this part of the judgment may attract less public attention than the infringement findings, it remains commercially important. The reasoning demonstrates the difficulty involved in using patent expiry arguments to attack established trade mark rights.
Key Takeaways from this dispute
The judgment carries broader implications for Australian brand owners, especially businesses operating in industries involving scientific, functional, or descriptive terminology.
Firstly, the decision confirms that even technically descriptive language can acquire substantial trade mark significance through consistent commercial use.
Secondly, the case highlights the importance of evidence. a2MC succeeded not merely because it possessed registrations, but because it produced detailed evidence showing how consumers actually recognized the brand.
Thirdly, the judgment demonstrates the risks associated with adopting branding that incorporates the dominant feature of a well-known mark, even where additional words or symbols are included.
The addition of “+” and “Care” did not sufficiently distance the branding from the established “a2” identity in the context of related goods.
Fourthly, the case illustrates how courts evaluate modern branding structures. Composite marks are not assessed mechanically. Courts look closely at which elements consumers are likely to remember and rely upon.
Finally, the decision reinforces the growing commercial value of reputation evidence in Australian intellectual property disputes.
Conclusion
The Federal Court’s decision in The a2 Milk Company Limited v Care A2 Plus Pty Ltd is a detailed and commercially significant judgment on modern Australian trade mark law.
Justice Rofe’s reasoning carefully balanced scientific terminology against commercial reality. Although “A2” possesses technical meaning within dairy science, the Court ultimately accepted that years of extensive use had transformed the expression into a powerful source identifier associated with a2MC.
The Court found that the use of “A2+” branding by the Care A2 Parties infringed the a2MC trade marks and contributed to a likelihood of consumer confusion. Attempts to invalidate the registrations on distinctiveness and other grounds were unsuccessful.
Beyond the dairy industry, the case provides broader guidance on acquired distinctiveness, deceptive similarity, composite branding, and consumer perception.
For trade mark owners, the decision is a strong reminder that reputation matters. A brand built consistently over time can obtain powerful legal protection, even where the underlying terminology once carried descriptive or scientific meaning.
For competitors entering crowded markets, the message is equally clear. Careful brand clearance and trade mark strategy remain essential before launching products that sit close to an established market identity.
Contact us to learn more about how LexGeneris can assist you with all your intellectual property needs. You can also schedule a no-cost consultation with our team of expert IP Attorneys Australia, IP Attorneys India, and IP Attorneys New Zealand
